Herve Hoppenot $INCY SEC Form 4 Insider Trading

Herve Hoppenot has filed a total of 1 insider trades in $INCY since 2021. Their most recent trade was a sale of 187,500 shares, made on Nov 10, 2025. Their largest trade was a sale of 187,500 shares, made on Nov 10, 2025. We estimate that they now own 326,803 shares of $INCY, worth an estimated $44.2 million.

Insider Trading at $INCY

There have been a total of 132 insider trades reported at $INCY since 2021, with 4.1 million shares purchased and 777,158 shares sold. The most active insider traders in $INCY stock have been Sheila A. Denton, Vijay K Iyengar, and Barry P Flannelly. The most recent trade was a sale of 10,856 shares reported by Mohamed Khairie Issa (EVP, Head of US Oncology), made on Jan 07, 2026.

$INCY Executives and Stock Owners with Insider Trades

• Sheila A. Denton, EVP & General Counsel

• Vijay K Iyengar, EVP, GMAPPS

• Barry P Flannelly, EVP & General Manager US

• Steven H Stein, EVP & Chief Medical Officer

• Thomas Tray, Principal Accounting Officer

• Maria E Pasquale, EVP & General Counsel

• Dashyant Dhanak, EVP & Chief Scientific Officer

• Jonathan Elliott Dickinson, EVP, General Manager, Europe

• Michael James Morrissey, EVP, Head of Tech. Operations

• Paula J Swain, EVP, Human Resources

• Patrick A Mayes, EVP & Chief Scientific Officer

• Paul Trower, Principal Accounting Officer

• Lee Heeson, EVP, Head of Incyte Intl

• Mohamed Khairie Issa, EVP, Head of US Oncology

• Vijay K Iyengar, EVP GPS, BD, & Licensing

• Yao Wenqing, EVP, Head of Discovery Chem

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.